newsfilter
← Latest News
GlobeNewswire·

ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19

First international patient enrolled in Brazil Trial approximately 75% enrolled rNAPc2 development focused on unmet need for treatments in hospitalized COVID-19 patients Topline trial data anticipated in the fourth quarter of 2021 WESTMINST